Transcriptomics Market Size, Share & Trends Analysis Report By Type (Instruments, Consumables, Software & Services), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Others), By Applications (Drug Discovery and Development, Diagnostics and Disease Profiling, Others), By End User (Academic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format:

Market Segmentation

  1. Transcriptomics Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Instruments
    2. Consumables
    3. Software & Services
  2. Transcriptomics Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Next-Generation Sequencing (NGS)
    2. Polymerase Chain Reaction (PCR)
    3. Microarray
    4. Others
  3. Transcriptomics Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Drug Discovery and Development
    2. Diagnostics and Disease Profiling
    3. Others
  4. Transcriptomics Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Academic and Research Institutes
    2. Pharmaceutical Companies
    3. Biotechnology Companies
    4. Others
  5. Regional Transcriptomics Market
    1. North America
      1. North America Transcriptomics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
        3. Software & Services
      2. North America Transcriptomics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
        3. Microarray
        4. Others
      3. North America Transcriptomics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery and Development
        2. Diagnostics and Disease Profiling
        3. Others
      4. North America Transcriptomics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutes
        2. Pharmaceutical Companies
        3. Biotechnology Companies
        4. Others
      5. U.S.
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      6. Canada
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
    2. Europe
      1. Europe Transcriptomics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
        3. Software & Services
      2. Europe Transcriptomics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
        3. Microarray
        4. Others
      3. Europe Transcriptomics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery and Development
        2. Diagnostics and Disease Profiling
        3. Others
      4. Europe Transcriptomics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutes
        2. Pharmaceutical Companies
        3. Biotechnology Companies
        4. Others
      5. U.K.
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      6. Germany
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      7. France
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      8. Spain
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      9. Italy
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      10. Russia
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      11. Nordic
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      12. Benelux
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      13. Rest of Europe
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
    3. APAC
      1. APAC Transcriptomics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
        3. Software & Services
      2. APAC Transcriptomics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
        3. Microarray
        4. Others
      3. APAC Transcriptomics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery and Development
        2. Diagnostics and Disease Profiling
        3. Others
      4. APAC Transcriptomics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutes
        2. Pharmaceutical Companies
        3. Biotechnology Companies
        4. Others
      5. China
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      6. Korea
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      7. Japan
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      8. India
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      9. Australia
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      10. Taiwan
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      11. South East Asia
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      12. Rest of Asia-Pacific
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
    4. Middle East and Africa
      1. Middle East and Africa Transcriptomics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
        3. Software & Services
      2. Middle East and Africa Transcriptomics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
        3. Microarray
        4. Others
      3. Middle East and Africa Transcriptomics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery and Development
        2. Diagnostics and Disease Profiling
        3. Others
      4. Middle East and Africa Transcriptomics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutes
        2. Pharmaceutical Companies
        3. Biotechnology Companies
        4. Others
      5. UAE
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      6. Turkey
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      7. Saudi Arabia
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      8. South Africa
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      9. Egypt
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      10. Nigeria
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      11. Rest of MEA
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
    5. LATAM
      1. LATAM Transcriptomics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
        3. Software & Services
      2. LATAM Transcriptomics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
        3. Microarray
        4. Others
      3. LATAM Transcriptomics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery and Development
        2. Diagnostics and Disease Profiling
        3. Others
      4. LATAM Transcriptomics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutes
        2. Pharmaceutical Companies
        3. Biotechnology Companies
        4. Others
      5. Brazil
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      6. Mexico
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      7. Argentina
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      8. Chile
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      9. Colombia
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others
      10. Rest of LATAM
        1. Instruments
        2. Consumables
        3. Software & Services
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Microarray
        7. Others
        8. Drug Discovery and Development
        9. Diagnostics and Disease Profiling
        10. Others
        11. Academic and Research Institutes
        12. Pharmaceutical Companies
        13. Biotechnology Companies
        14. Others

We are featured on: